Heart failure and mitochondrial dynamics: Role of intracellular angiotensin and emerging therapeutics
Mitochondrion · 2026
DOI: 10.1016/j.mito.2026.102173 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mitochondrion, 2026. Verfasst von Pranav Panchbhai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: panchbhaipranav@gmail.com. Hauptthemen laut MEDLINE: Heart Failure, Mitochondrial Dynamics, Angiotensin II, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) remains a leading cause of morbidity and mortality worldwide despite significant advances in neurohumoral therapies targeting the renin-angiotensin-aldosterone (RAAS). Although RAAS inhibition improves survival and limits adverse cardiac remodelling in failing hearts, mitochondrial dynamic dysfunction persists in a larger proportion of treated patients, indicating an intracellular signalling mechanism that sustains the pathological remodelling in these patients. Emerging evidence shows a shift toward a fission-dominant mitochondrial phenotype, acting as a critical feature of a failing heart. Angiotensin II (Ang II), beyond its classical endocrine actions, activates a network of calcium- and redox-dependent intracellular signalling pathways that converge on the mitochondrial fission machinery. Many of these components are incompletely inhibited by the conventional RAAS blockade, providing a mechanistic basis for RAAS escape and persistent mitochondrial dysfunction. This review highlights the mechanism underlying the temporal stabilization of fission-dominant mitochondrial phenotype, and discusses the opportunity to target mitochondrial dynamics as a complementary therapeutic strategy. Reframing angiotensin signalling through the lens of mitochondrial dysregulated dynamics may help overcome the limitations of current heart failure therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: panchbhaipranav@gmail.com.
- Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: satnammehadwan060@gmail.com.
- Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: chaturvedigauri97@gmail.com.
- Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: dubeynandini2015@gmail.com.
- Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India. Electronic address: prabhakaremf@gmail.com.
- Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: neerajparakh@yahoo.com.
Zitieren
APA
Panchbhai, P., Mehadwan, S. S., Chaturvedi, G., Dubey, N., Singh, P., Parakh, N., Baitha, U., Prakash, V., Narang, R., Agrawal, D. K., & Yadav, H. N. (2026). Heart failure and mitochondrial dynamics: Role of intracellular angiotensin and emerging therapeutics. Mitochondrion. https://doi.org/10.1016/j.mito.2026.102173
Vancouver
Panchbhai P, Mehadwan SS, Chaturvedi G, Dubey N, Singh P, Parakh N, et al. Heart failure and mitochondrial dynamics: Role of intracellular angiotensin and emerging therapeutics. Mitochondrion. 2026. doi:10.1016/j.mito.2026.102173
BibTeX
@article{Panchbhai2026,
author = {Panchbhai, Pranav and Mehadwan, Satnam Singh and Chaturvedi, Gauri and Dubey, Nandini and Singh, Prabhakar and Parakh, Neeraj and Baitha, Upendra and Prakash, Ved and Narang, Rajiv and Agrawal, Devendra K and Yadav, Harlokesh Narayan},
title = {Heart failure and mitochondrial dynamics: Role of intracellular angiotensin and emerging therapeutics},
journal = {Mitochondrion},
year = {2026},
doi = {10.1016/j.mito.2026.102173}
}
EUVIMED